Company Information

CIN
Status
Date of Incorporation
04 September 2006
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
1,131,628,800
Authorised Capital
1,155,000,000

Directors

Jyoti Loomba
Jyoti Loomba
Director/Designated Partner
over 2 years ago
Piyush Kumar Gupta
Piyush Kumar Gupta
Director/Designated Partner
over 2 years ago

Past Directors

Kiran Kumar Manikwar
Kiran Kumar Manikwar
Company Secretary
about 8 years ago
Satyendra Kumar Singh
Satyendra Kumar Singh
Director
over 13 years ago
Pranav Kumar Tyagi
Pranav Kumar Tyagi
Additional Director
over 14 years ago
Shashi Shanker Parsad Singh
Shashi Shanker Parsad Singh
Director
about 17 years ago
Sarah Loomba
Sarah Loomba
Alternate Director
about 17 years ago
Avdhesh Maheshwari
Avdhesh Maheshwari
Additional Director
almost 19 years ago
Sanjay Loomba
Sanjay Loomba
Director
over 19 years ago

Patents

Stable Antimicrobial Injectable Composition

The present invention relates to the field of parenteral pharmaceuticals. The invention specifically relates to parenteral preparations of antimicrobial agent and methods for the preparation of the same. The present invention more specifically relates to linezolid injection composition comprising propylene glycol an...

Stable Injectable Composition Of Oxazolidinone

ABSTRACT The present invention relates to a parenteral preparation of antimicrobial agent. The present invention specifically relates to a parenteral preparation of oxazolidinone antimicrobial agent. The present invention specifically relates to a stable concentrated linezolid injection composition comprising Hydro...

Edta Injection And Process For Making The Same

The present invention relates to the field of parenteral preparations. The invention specifically relates to parenteral preparations comprising Ethylenediaminetetraacetic acid (EDTA) and water for injection. The present invention also relates to procedure for manufacturing parenteral preparations comprising Ethylene...

Novel Non Oral Formulations Of Factor Xa Inhibitors And Process For Preparation Thereof

ABSTRACT NOVEL NON-ORAL FORMULATIONS OF FACTOR Xa INHIBITORS AND PROCESS FOR PREPARATION THEREOF The present invention relates to a novel non-oral formulation of factor Xa inhibitors comprising factor Xa inhibitor and pharmaceutically acceptable excipients selected from vehicles, surface active agents, co-solvents ...

Liposomal Composition Of Doxorubicin And Irinotecan And Process For Preparation Thereof

ABSTRACT LIPOSOMAL COMPOSITION OF DOXORUBICIN AND IRINOTECAN AND PROCESS FOR PREPARATION THEREOF The present invention relates to liposomal composition of Doxorubicin and Irinotecan. The present invention also relates to liposomal composition of Doxorubicin or its pharmaceutically acceptable salt and Irinotecan ...

Liposomal Composition Of Idarubicin And Cytarabine And Process For Preparation Thereof

ABSTRACT LIPOSOMAL COMPOSITION OF IDARUBICIN AND CYTARABINE AND PROCESS FOR PREPARATION THEREOF The present invention relates to liposomal composition of Idarubicin and Cytarabine. The present invention also relates to liposomal composition of Idarubicin and Cytarabine comprising one or more excipients, wherein ...

Registered Trademarks

Oncoprism Jodas Expoim

[Class : 5] Pharmaceutical Preparations For Use In Oncology, Pharmaceutical Preparations And Substances For Use In Oncology.

Johaler Jodas Expoim

[Class : 5] Pharmaceuticals.

Josalf Jodas Expoim

[Class : 5] Pharmaceuticals.
View +121 more Brands for Jodas Expoim Private Limited.

Charges

39 Crore
31 May 2019
Hdfc Bank Limited
39 Crore
19 April 2016
Axis Bank Limited
6 Lak
10 October 2017
Shinhan Bank
35 Crore
20 August 2015
Axis Bank Limited
17 Crore
07 November 2023
Others
0
19 April 2016
Axis Bank Limited
0
20 August 2015
Axis Bank Limited
0
31 May 2019
Hdfc Bank Limited
0
10 October 2017
Others
0
07 November 2023
Others
0
19 April 2016
Axis Bank Limited
0
20 August 2015
Axis Bank Limited
0
31 May 2019
Hdfc Bank Limited
0
10 October 2017
Others
0